AstraZeneca
AZN
#51
Rank
HK$2.184 T
Marketcap
HK$1,408
Share price
-1.52%
Change (1 day)
3.38%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): HK$55.75

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$55.86. In 2024 the company made an earnings per share (EPS) of HK$35.62 an increase over its 2023 EPS that were of HK$30.13.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$55.75
2024HK$35.6218.23%
2023HK$30.1381.13%
2022HK$16.63631.03%
2021HK$2.28-88.11%
2020HK$19.14136.89%
2019HK$8.08-39.41%
2018HK$13.34-28.27%
2017HK$18.60-14.37%
2016HK$21.7224.11%
2015HK$17.50127.55%
2014HK$7.69-51.96%
2013HK$16.01-58.95%
2012HK$39.00-32.2%
2011HK$57.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-6.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.19-26.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-90.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$21.21-62.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.37 333.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.54-72.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$18.52-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.46-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.58-59.59%๐Ÿ‡ฌ๐Ÿ‡ง UK